A detailed history of Monument Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Monument Capital Management holds 2,842 shares of LLY stock, worth $2.57 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
2,842
Previous 2,916 2.54%
Holding current value
$2.57 Million
Previous $2.27 Million 13.45%
% of portfolio
0.78%
Previous 0.67%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $53,640 - $67,268
-74 Reduced 2.54%
2,842 $2.57 Million
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $22,503 - $30,106
38 Added 1.32%
2,916 $2.27 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $40,964 - $48,292
78 Added 2.79%
2,878 $1.68 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $9,128 - $12,585
21 Added 0.76%
2,800 $1.5 Million
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $57,872 - $77,381
165 Added 6.31%
2,779 $1.3 Million
Q1 2023

Apr 21, 2023

SELL
$310.63 - $364.82 $70,823 - $83,178
-228 Reduced 8.02%
2,614 $897,000
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $76,850 - $89,546
239 Added 9.18%
2,842 $0
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $298,851 - $340,572
-1,008 Reduced 27.91%
2,603 $842,000
Q2 2022

Jul 20, 2022

BUY
$278.73 - $327.27 $108,147 - $126,980
388 Added 12.04%
3,611 $1.17 Million
Q1 2022

Apr 14, 2022

BUY
$234.69 - $291.66 $234,690 - $291,660
1,000 Added 44.98%
3,223 $923,000
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $23,834 - $29,578
106 Added 5.01%
2,223 $614,000
Q3 2021

Oct 22, 2021

BUY
$221.6 - $272.71 $9,972 - $12,271
45 Added 2.17%
2,117 $489,000
Q2 2021

Jul 27, 2021

BUY
$180.55 - $233.54 $73,122 - $94,583
405 Added 24.3%
2,072 $476,000
Q1 2021

Apr 12, 2021

SELL
$164.32 - $212.72 $2.35 Million - $3.04 Million
-14,307 Reduced 89.56%
1,667 $311,000
Q4 2020

Jan 15, 2021

BUY
$130.46 - $172.63 $79,580 - $105,304
610 Added 3.97%
15,974 $2.7 Million
Q3 2020

Oct 23, 2020

SELL
$146.22 - $169.13 $47,667 - $55,136
-326 Reduced 2.08%
15,364 $2.27 Million
Q2 2020

Jul 16, 2020

SELL
$136.42 - $164.18 $136,829 - $164,672
-1,003 Reduced 6.01%
15,690 $2.58 Million
Q1 2020

Apr 14, 2020

BUY
$119.05 - $147.35 $18,809 - $23,281
158 Added 0.96%
16,693 $2.32 Million
Q4 2019

Jan 14, 2020

BUY
$106.92 - $132.43 $8,019 - $9,932
75 Added 0.46%
16,535 $2.17 Million
Q3 2019

Oct 21, 2019

SELL
$106.79 - $116.16 $51,259 - $55,756
-480 Reduced 2.83%
16,460 $1.84 Million
Q2 2019

Jul 23, 2019

SELL
$110.79 - $129.32 $38,333 - $44,744
-346 Reduced 2.0%
16,940 $1.91 Million
Q1 2019

Apr 10, 2019

SELL
$111.31 - $131.02 $89,827 - $105,733
-807 Reduced 4.46%
17,286 $2.24 Million
Q4 2018

Jan 15, 2019

BUY
$105.9 - $118.64 $1.84 Million - $2.06 Million
17,380 Added 2437.59%
18,093 $2.09 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $61,218 - $76,512
713 New
713 $77,000
Q3 2018

Oct 11, 2018

SELL
$85.86 - $107.31 $44,046 - $55,050
-513 Closed
0 $0
Q4 2017

Feb 05, 2018

BUY
$81.94 - $87.89 $42,035 - $45,087
513
513 $43,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Monument Capital Management Portfolio

Follow Monument Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Monument Capital Management with notifications on news.